JP2023545372A5 - - Google Patents
Info
- Publication number
- JP2023545372A5 JP2023545372A5 JP2023518752A JP2023518752A JP2023545372A5 JP 2023545372 A5 JP2023545372 A5 JP 2023545372A5 JP 2023518752 A JP2023518752 A JP 2023518752A JP 2023518752 A JP2023518752 A JP 2023518752A JP 2023545372 A5 JP2023545372 A5 JP 2023545372A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- hypomania
- mania
- dexmedetomidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089135P | 2020-10-08 | 2020-10-08 | |
| US63/089,135 | 2020-10-08 | ||
| PCT/US2021/054171 WO2022076818A1 (en) | 2020-10-08 | 2021-10-08 | Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545372A JP2023545372A (ja) | 2023-10-30 |
| JP2023545372A5 true JP2023545372A5 (https=) | 2024-10-15 |
Family
ID=81126063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518752A Pending JP2023545372A (ja) | 2020-10-08 | 2021-10-08 | デクスメデトミジン塩酸塩を用いた双極性障害及び精神病の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240024289A1 (https=) |
| EP (1) | EP4225305A4 (https=) |
| JP (1) | JP2023545372A (https=) |
| KR (1) | KR20230084186A (https=) |
| CN (1) | CN116615243A (https=) |
| AU (1) | AU2021356687A1 (https=) |
| CA (1) | CA3195133A1 (https=) |
| IL (1) | IL301971A (https=) |
| MX (1) | MX2023003993A (https=) |
| TW (1) | TW202228682A (https=) |
| WO (1) | WO2022076818A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL267689B2 (en) | 2016-12-31 | 2025-05-01 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| BR112020026672A2 (pt) | 2018-06-27 | 2021-03-30 | Bioxcel Therapeutics, Inc. | Formulações de filme contendo dexmedetomidina e métodos para produzi-las |
| BR112022000992A2 (pt) | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| CA2884926C (en) * | 2012-10-15 | 2021-09-21 | Orion Corporation | A veterinary method of alleviating noise aversion |
| KR101881791B1 (ko) * | 2013-10-07 | 2018-07-25 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정성 덱스메데토미딘 경피 조성물을 사용하여 금단 증후군을 치료하기 위한 방법 및 조성물 |
| IL267689B2 (en) * | 2016-12-31 | 2025-05-01 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| BR112022000992A2 (pt) * | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
-
2021
- 2021-10-08 US US18/030,405 patent/US20240024289A1/en active Pending
- 2021-10-08 TW TW110137597A patent/TW202228682A/zh unknown
- 2021-10-08 AU AU2021356687A patent/AU2021356687A1/en not_active Abandoned
- 2021-10-08 IL IL301971A patent/IL301971A/en unknown
- 2021-10-08 CN CN202180069020.2A patent/CN116615243A/zh active Pending
- 2021-10-08 KR KR1020237013556A patent/KR20230084186A/ko not_active Withdrawn
- 2021-10-08 MX MX2023003993A patent/MX2023003993A/es unknown
- 2021-10-08 WO PCT/US2021/054171 patent/WO2022076818A1/en not_active Ceased
- 2021-10-08 EP EP21878615.0A patent/EP4225305A4/en not_active Withdrawn
- 2021-10-08 JP JP2023518752A patent/JP2023545372A/ja active Pending
- 2021-10-08 CA CA3195133A patent/CA3195133A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023545372A5 (https=) | ||
| JP2023041862A5 (https=) | ||
| JP2025092508A5 (https=) | ||
| JP2023076465A5 (https=) | ||
| JP2024109585A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2023503068A5 (https=) | ||
| BR9814378A (pt) | Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| JP2025020117A5 (https=) | ||
| JP2022163049A5 (https=) | ||
| JP2021152008A5 (https=) | ||
| JP2023175694A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| FI3746126T3 (fi) | Menetelmiä ja koostumuksia uniapnean tai pelkän kuorsauksen hoitamiseksi | |
| JP2005507892A5 (https=) | ||
| JP2023522010A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| JP2021529829A5 (https=) | ||
| JP2005508963A5 (https=) | ||
| JP2021073257A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2019514990A5 (https=) | ||
| JP2007509146A5 (https=) |